Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s):  CLAZF

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.


TSXV:CLAS.H - Post by User

Comment by kingcarteron Dec 14, 2010 11:57pm
554 Views
Post# 17847876

RE: Can someone please tell me..

RE: Can someone please tell me..BNN has issues with its player. Most of the bits are cut short so the part about QEI is cut out (another example: the part with Don Vialoux is mish-mashed with Charles Dillingham). 

They have some bugs to work out. I just watched the replay.

Basically said news is "imminent" ... he has a small piece ... Sprott as a whole has 19.9% ... some future success is priced into the stock already ... probably an 8 well drill program for this year ... briefly mentioned a farm in in Guatemala where Pacific Rubialis is looking.

As some said he was being very cautious approach to his commentary. Some have implied they think that's a good thing for whatever reason. I'm guessing those are the same people that think any piece of news is good news. Anyway, I don't like the caution as much because it tells me he's not confident. However, I've noticed Sprott's people will sound like bulls on a stock before they get out and neutral if they're waiting on news.

Good to hear some talk on it ... but I'm waiting for news to see what my next step is. I generally like drill programs though. If theres a nice kick I'll sell some and stash some away and not look at it for a while.

WoW ... GLTATL
Bullboard Posts